ACM
RIGL icon

Aquatic Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Aquatic Capital Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.16M Buy
+42,782
New +$1.44M 0.03% 528
2025
Q4 		– Sell
-7,775
Closed -$220K – 1715
2025
Q3 		$220K Buy
7,775
+2,751
+55% +$82.3K ﹤0.01% 1076
2025
Q2 		$94.1K Buy
5,024
+4,896
+3,825% +$92.8K ﹤0.01% 1098
2025
Q1 		$2.3K Buy
+128
New +$2.6K ﹤0.01% 1206
2022
Q3 		– Sell
-120
Closed -$1K – 1490
2022
Q2 		$1K Buy
+120
New +$2.41K ﹤0.01% 1133
2022
Q1 		– Sell
-1,320
Closed -$35K – 1452
2021
Q4 		$35K Buy
+1,320
New +$39.8K 0.07% 418

Other funds holding RIGL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return